全文获取类型
收费全文 | 879篇 |
免费 | 245篇 |
国内免费 | 15篇 |
专业分类
儿科学 | 11篇 |
妇产科学 | 2篇 |
基础医学 | 103篇 |
口腔科学 | 2篇 |
临床医学 | 164篇 |
内科学 | 252篇 |
皮肤病学 | 1篇 |
神经病学 | 8篇 |
特种医学 | 5篇 |
外科学 | 6篇 |
综合类 | 77篇 |
现状与发展 | 3篇 |
预防医学 | 482篇 |
眼科学 | 2篇 |
药学 | 14篇 |
肿瘤学 | 7篇 |
出版年
2024年 | 2篇 |
2023年 | 49篇 |
2022年 | 49篇 |
2021年 | 88篇 |
2020年 | 116篇 |
2019年 | 80篇 |
2018年 | 109篇 |
2017年 | 63篇 |
2016年 | 69篇 |
2015年 | 101篇 |
2014年 | 82篇 |
2013年 | 61篇 |
2012年 | 47篇 |
2011年 | 36篇 |
2010年 | 49篇 |
2009年 | 33篇 |
2008年 | 15篇 |
2007年 | 17篇 |
2006年 | 9篇 |
2005年 | 13篇 |
2004年 | 8篇 |
2003年 | 9篇 |
2002年 | 4篇 |
2001年 | 2篇 |
2000年 | 5篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 3篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1988年 | 3篇 |
1968年 | 1篇 |
排序方式: 共有1139条查询结果,搜索用时 46 毫秒
31.
32.
《Vaccine》2018,36(35):5265-5272
Annual influenza vaccination is recommended to people with chronic conditions. This study aimed to estimate the proportion of chronically ill adults vaccinated against influenza in consecutive seasons and to identify associated factors.We used data from the first National Health Examination Survey (INSEF), a cross-sectional study conducted in 2015 on a probabilistic sample of individuals aged 25–74 years. The population was restricted to individuals who self-reported diabetes, a respiratory, cardiovascular, liver or kidney disease. Self-reported vaccination in 4 consecutive seasons was categorized in 3 levels: unvaccinated, occasionally (vaccinated 1–3 seasons) and repeatedly vaccinated (in all 4 seasons). A multinomial logistic regression was applied to estimate odds-ratio (OR) of influenza vaccination according to sociodemographic factors, chronic condition, health care use and status.In the target population, the 2014/15 influenza vaccine coverage was 33.8% (95% CI: 29.8–38.1). The higher coverage was found in individuals reporting renal disease (66.7%) and diabetes (43.8%). The coverage decreased to 32.6%, 26.0% and 20.8% for individuals with respiratory, cardiovascular and liver diseases, respectively. The probability of being repeatedly vaccinated, compared to unvaccinated, was higher in males (OR = 2.14: 95% CI: 1.31–3.52); aged 65 and 74 (OR = 4.39; 95% CI: 1.99–9.69); whom had an appointment with a general practitioner (OR = 2.77; 95% CI: 1.00–7.66) or other physician (OR = 3.95: 95% CI: 2.53–6.16); with no smoking habits (OR = 1.58; 95% I: 1.02–2.46) and reporting diabetes (OR = 2.13; 95% CI: 1.02–4.45). Finally, having a self-reported cardiovascular condition decreased the likelihood of being occasionally (OR = 0.38; 95% CI = 0.22–0.65) vaccinated against influenza.Younger individuals, females and the ones with a self-reported cardiovascular condition were identified as more likely of non-compliance to the vaccine uptake recommendation. Future vaccination strategies should focus on the previous identified population subgroups. Also, the medical recommendation of the influenza vaccine uptake should continue and be reinforced particularly in individuals with a cardiovascular condition. 相似文献
33.
34.
35.
36.
目的 检测巴尔通体菌株对10类19种抗生素最低抑菌浓度(MICs),分析药物敏感性及耐药性,为指导临床用药和耐药监测提供实验和数据参考。方法 采用E试验法,检测巴尔通体属11种、35株菌株对强力霉素、阿奇霉素、利福平等19种抗生素的MICs。将培养的巴尔通体菌制成McFarland(MCF)2.0浊度的菌悬液,均匀涂布于含5%去纤维羊血的胰酶大豆琼脂培养基上,置5% CO2的37℃培养箱培养。培养5~7 d后判读MICs。结果 35株巴尔通体菌在体外对强力霉素、阿奇霉素、红霉素、克拉仙霉素等13种抗生素敏感,MICs 0.016 mg/L;34株对利福平敏感,MICs 0.002 mg/L;对克林霉素、丁胺卡那霉素、万古霉素、多粘菌素和磺胺类5种抗生素不敏感,MICs较高。结论 绝大多数巴尔通体菌对强力霉素等14种抗生素敏感,但也对克林霉素等5种抗生素不敏感,在对巴尔通体病进行治疗时要注意选择敏感药物。 相似文献
37.
目的 通过对新疆维吾尔自治区(新疆)1995-2016年伤寒沙门菌进行分子流行学特征分析,为今后监测和疫情预警提供依据。方法 利用脉冲场凝胶电泳(PFGE)对527株伤寒沙门菌进行分子分型和流行特征研究。结果 527株伤寒沙门菌分为145个PFGE带型,条带相似度为57.42%~100.00%。有部分带型多年持续存在,且出现在不同地区。共发现32组分子分型成簇性病例。结论 新疆伤寒沙门菌在基因型上存在高度多态性,同时也有优势带型长期连续存在,且存在分子分型成簇性病例,需要加强实验室监测。 相似文献
38.
目的 分析2015-2016年伤寒、副伤寒法定报告病例数,了解全国及高发省份流行病学特点和变化趋势,为防控措施和策略的制定提供依据。方法 采用描述性流行病学方法对网络直报系统中2015-2016年伤寒、副伤寒报告病例数进行分析。结果 2015-2016年全国共报告伤寒、副伤寒病例22 536例,死亡2例,年平均发病率为0.83/10万,较2014年的伤寒、副伤寒发病率下降18.63%。监测点共对14 465份血样标本进行培养,分离出菌株289株,阳性分离率为2.00%,伤寒与副伤寒之比为1.21:1。病例均以农民和民工为主,其次为散居儿童和在校学生,伤寒、副伤寒发病率均以0~4岁组儿童最高(分别为1.70/10万和0.80/10万)。贵州、云南、广西、广东、浙江、湖南和新疆为疫情高发省份,非监测点病例数上升。结论 2015-2016年全国伤寒、副伤寒发病水平处于相对较低的状态,<10岁儿童是防控重点人群,伤寒菌成为优势菌型,应加强非监测点疫情监测。 相似文献
39.
《American journal of infection control》2021,49(11):1448-1449
Using a 1989 baseline study, we surveyed 1,004 US consumers in 2019 on education and awareness of healthcare-associated infection (HAI) risk and prevention. Awareness of HAI risk remains unchanged (62% vs 65%) but belief HAIs are preventable dropped (83% vs 28%). Medical professionals and the internet are top information sources. 相似文献
40.
《Vaccine》2015,33(22):2558-2561
BackgroundImmunological studies have indicated that the effectiveness of AS03 adjuvanted monovalent influenza A(H1N1)pdm09 vaccine (Pandemrix®) may be of longer duration than what is seen for non-adjuvanted seasonal influenza vaccines. Sixty-nine percent of children 6 months–18 years of age in Stockholm County received at least one dose of Pandemrix® during the 2009 pandemic. We studied the effectiveness of the vaccine during the influenza seasons 2010–2011 and 2012–2013 in children hospitalized with virologically confirmed influenza. The season 2011–2012 was not included, since influenza A(H3N2) was the predominant circulating strain.MethodsIn a retrospective case-control study using a modified test-negative design we compared the percentage vaccinated with Pandemrix® among children diagnosed with influenza A(H1N1)pdm09 (cases), with that of those diagnosed with influenza A(H3N2) or influenza B (controls) during the two seasons. We excluded children born after July 1, 2009, since only children who were 6 months of age or older received the pandemic vaccine in October–December 2009.ResultsDuring the 2010–2011 season, 3/16 (19%) of children diagnosed with influenza A(H1N1)pdm09, vs. 32/41 (78%) of those with influenza A(H3N2) or influenza B had been vaccinated with Pandemrix® in 2009. The odds ratio, after adjustment for sex, age and underlying diseases, for becoming a case when vaccinated with Pandemrix® was 0.083 (95%CI 0.014, 0.36), corresponding to a VE of 91.7%. During the season 2012–2013, there was no difference between the two groups; 59% of children diagnosed with influenza A(H3N2)/B and 60% of those with influenza A(H1N1)pdm09 had been vaccinated with Pandemrix® in 2009.ConclusionThe AS03 adjuvanted monovalent influenza A(H1N1) pdm09 vaccine (Pandemrix®) was effective in preventing hospital admission for influenza A(H1N1)pdm09 in children during at least two seasons. 相似文献